Prudential Hong Kong in a strategic partnership with Foshan Fosun Chancheng hospital and the Hong Kong Integrated Oncology Centre will further expand cross-border medical expenses direct billing services for cancer treatment across the Greater Bay Area.
This collaboration aims to provide more seamless and convenient cross-border healthcare services through the “Cancer Patients Shared Care” model, addressing the growing demand for high-quality medical services in the region.
According to a press release by Prudential by bringing together the strengths of three leading providers, the collaboration creates synergies to deliver innovative and comprehensive health solutions, demonstrating Prudential’s commitment to supporting customers along their healthcare journey when they need it the most.
Statistics show that in Hong Kong, one person is diagnosed with cancer every 15 minutes. On the Chinese mainland, the figure is even more concerning, with nine people diagnosed every minute. In 2020 alone, the number of newly diagnosed male lung cancer patients reached approximately 540,000 and breast cancer cases rose by around 420,000.
These figures underline the growing threat cancer poses to the health of residents in both regions. Furthermore, Prudential’s 2024 Individual Life Claims Report shows that cancer is the leading cause of both critical illness and death claims, highlighting its significant impact on individuals’ health and financial well-being.
Prudential Hong Kong CEO Lawrence Lam said, “This strategic alliance marks a significant milestone in Prudential’s on-going efforts to enhance its patient-centred healthcare ecosystem. Prudential remains dedicated to its customer-first philosophy and will continue to deliver comprehensive and innovative protection solutions, fostering healthcare integration in the Greater Bay Area.”
Shanghai Fosun Health Technology and director of Foshan Fosun Chancheng Hospital Hu Hang said, “The key breakthrough in this tripartite collaboration lies in truly bridging the ‘last mile’ for Hong Kong patients seeking medical care in the Chinese mainland. We integrate Hong Kong’s precision medicine strengths with high-quality the Chinese Mainland resources to offer Hong Kong patients a one-stop support — from appointment and referral to medical expenses direct billing.”
Hong Kong Integrated Oncology Centre CEO Tong Ka Kei said, “Building on the collaborative achievements from the end of 2023, Prudential is now extending its services to Foshan, further strengthening cross-border healthcare connectivity in oncology. Moving forward, we will continue working closely with partners from various sectors to further energise cross-border healthcare collaboration.”
